Value Investing through Gurus model portfolios. | Equity School | - M - Marksans Pharma Ltd

You are here: Home

Balance Sheet of Marksans Pharma Ltd

Balance Sheet of Marksans Pharma Ltd

	Mar2008	Mar2007	Mar2006	Mar2005	Mar2004
SOURCES OF FUNDS:
Share Capital	49.44	49.44	49.44	49.44	33.50
Reserves & Surplus	92.04	77.12	70.19	52.68	10.72
Total Shareholders Funds	141.48	126.56	119.63	102.12	44.22
Secured Loans	103.26	100.77	80.67	83.37	87.57
Unsecured Loans	199.85	217.95	223.20	4.20	5.41
Total Debt	303.11	318.72	303.87	87.57	92.98
Total Liabilities	444.59	445.28	423.50	189.69	137.20
APPLICATION OF FUNDS:
Gross Block	252.09	177.13	156.24	125.20	97.63
Less: Accum. Depreciation	47.03	38.61	31.37	23.56	16.61
Net Block	205.06	138.52	124.87	101.64	81.02
Capital Work in Progress	0.00	0.00	0.00	0.00	0.00
Investments	2.70	2.69	0.01	0.26	0.26
Inventories	123.70	123.46	78.91	48.52	34.04
Sundry Debtors	52.86	53.33	50.69	57.20	50.87
Cash and Bank Balance	43.20	158.45	197.61	9.51	4.23
Loans and Advances	75.31	22.60	15.34	12.90	5.74
Current Liabilities	58.20	54.97	41.29	40.20	40.59
Provisions	1.12	0.70	4.54	2.23	1.03
Net Current Assets	235.75	302.17	296.72	85.70	53.26
Miscellaneous Expenses not w/o	1.08	1.90	1.90	2.09	2.66
Total Assets	444.59	445.28	423.50	189.69	137.20
Contingent Liabilities	3.50	17.09	21.05	3.93	3.73

High Dividend, High Value, Fast Growth - Stock Research Based on Strategies of the Pros, including Warren Buffett, Peter Lynch and Ben Graham